Court Orders Illumina to Pay Syntrix $96M for Patent Infringement | GenomeWeb

NEW YORK (GenomeWeb News) – A federal court jury has ordered Illumina to pay $96 million in damages to Syntrix Biosystems in a patent infringement case.

According to the jury, Illumina infringed Syntrix's US Patent No. 6,951,682 through the sale of its BeadChip array products. The damage award is based on a royalty rate of 6 percent for BeadChip products that were sold by Illumina between 2005 and 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.